Seeking Alpha

Sucampo (SCMP +0.6%) bucks a weak tape after saying that the Japanese Science and Technology...

Sucampo (SCMP +0.6%) bucks a weak tape after saying that the Japanese Science and Technology Agency has adopted the company's unoprostone isopropyl ophthalmic solution into its Technology Transfer Program. As part of the program, Japanese development partner R-Tech Ueno has signed an agreement with the agency to provide the majority of funding for Phase 3 clinical development costs for its treatment of retinitis pigmentosa. SCMP is planning to file for FDA approval pending the successful trials.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|